TRU2023-04-012023-06-30 TRU2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member TRU2023-06-30 TRU2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 540268 TRU NA TruCap Finance Limited Equity 2023-04-01 2024-03-31 2023-08-11 2023-08-03 INR Lakhs First quarter 2023-08-11 16:30:00 2023-08-11 18:05:00 false Not applicable Single segment NA 2023-04-01 2023-06-30 Unaudited Standalone 266011000.00 0.00 0.00 105986000.00 5776000.00 0.00 0.00 0.00 377773000.00 15000.00 377788000.00 0.00 0.00 0.00 88558000.00 173396000.00 16473000.00 2630000.00 0.00 0.00 11223000.00 68644000.00 360924000.00 16864000.00 0.00 16864000.00 5870000.00 -1646000.00 4224000.00 12640000.00 0.00 0.00 0.00 0.00 12640000.00 75000.00 12715000.00 0.00 0.00 232546000.00 2 0.11 0.11 0.00 0.00 0.11 0.11 0.02 0.00 0.00 1 Fee and commission income includes advisory service fee and commission from syndication loan. 2 The above results for the quarter ended June 30, 2023 have been reviewed and recommended by the Audit Committee and subsequently approved by the Board of Directors at their respective meetings held on August 11, 2023. 3 The standalone financial results for the quarter ended June 30, 2023 have been limited reviewed by the Statutory Auditors and they have issued an unmodified opinion. 4 The Company has primarily two reportable business segments namely Fund based Activities and Advisory services for the quarter June 30, 2023. The Company publishes unaudited standalone financial results along with the unaudited consolidated financial results and in accordance with Ind AS 108 - Operating Segments, the Company has disclosed the segment information in the unaudited consolidated financial results of the Company. 5 During the quarter ended June 30, 2023, the equity shares of the Company were listed and admitted to dealings on the National Stock Exchange of India Limited (NSE) with effect from June 20, 2023. 6 During the quarter ended June 30, 2023, the Company has allotted 58,175 equity shares to eligible ESOP holder upon exercise of Options held by him. 7 During the quarter ended June 30, 2023, there were no fresh preferential issue in the Company and there were no outstanding listed non-convertible securities (NCS) during the quarter ended June 30, 2023. Accordingly, the disclosures under regulation 32(1) of the Listing Regulations with respect to fund utilization and disclosures pertaining to the NCS as required under Chapter V of the Listing Regulations are not required to be given. 8 Disclosure pertaining to RBI Master Direction - RBI/DOR/2021-22/86 DOR.STR.REC.51/21.04.048/2021-22 Reserve Bank of India (Transfer of Loan Exposures) Directions, 2021 dated September 24, 2021 - During the quarter ended June 30, 2023 the Company not transferred/assigned any loan exposures. 9 Disclosure as required undermaster Direction – Reserve Bank of India (Securitisation of Standard Assets) Directions, 2021, issued by the Reserve Bank of India on September 24, 2021 is as under: Details of stressed loans transferred during the year (NPA) : To ARCs No of accounts : 74 Aggregate principal outstanding of loan transferred (Rs. In Lakhs) : 733.33 Weighted average residual tenor of the loan transferred (in months) : 20 Net Book Value of loans transferred (at the time of transfer) : 733.33 Aggregate consideration : 725.00 Rating wise distribution of rated loans : NA 10 The figures for the Fourth quarter of the previous financial year are the balancing figures between audited figures in respect of the full financial year and the published year to date figures upto the end of third quarter of the previous financial year which was subject to limited review by the statutory auditors. 11 The figures for the previous quarter/year have been regrouped / rearranged wherever necessary to conform to the current quarter presentation. For and on behalf of the Board of TruCap Finance Limited Sd/- Rohanjeet Singh Juneja Managing Director and Chief Executive Officer DIN: 08342094 Mumbai, August 11, 2023 Other Expenses 68644000.00 0.00 0.00 0.00 0.00 Remeasurement gain/(loss) on defined benefit plan 104000.00 104000.00 29000.00 0.00 75000.00